More on KPRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/9/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Kiora Pharmaceuticals (NQ:KPRX)
Delayed: 2.51 --0 (-0%)
Prev. Close $2.51  
Open$2.54 
52 Wk High$ 
52 Wk Low$ 
Day High$2.54 
Day Low$2.50 
P/E N/A  
EPS$ 
Volume7,331 

Friends, Peers and Foes (?): RBOT WS (more...)

Aug 19, 2026 07:02 AM Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation
Aug 19, 2026 07:01 AM Form 8-K KIORA PHARMACEUTICALS For: Aug 19
Aug 14, 2026 05:04 PM Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: ADAR1 Capital Management, LLC
Aug 14, 2026 04:49 PM Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: Nantahala Capital Management, LLC
Aug 10, 2026 11:59 AM Form SCHEDULE 13G KIORA PHARMACEUTICALS Filed by: PERCEPTIVE ADVISORS LLC
Aug 7, 2026 07:34 AM Kiora Pharmaceuticals (KPRX) Tops Q2 EPS by 17c
Aug 7, 2026 07:03 AM Form 8-K KIORA PHARMACEUTICALS For: Aug 07
Aug 7, 2026 07:03 AM Form 10-Q KIORA PHARMACEUTICALS For: Jun 30
Aug 7, 2026 07:03 AM Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Jul 2, 2026 04:47 PM Form 4 KIORA PHARMACEUTICALS For: Jul 01 Filed by: Tosca Melissa
View All Articles

Entities mentioned with KPRX

View All Entities